 Stephen E. Sallan, MD
Previous |
Next
 |
Return to Search Results
Departments/Divisions
Hematology/Oncology
Medicine
Specialties
acute lymphoblastic leukemia (ALL)
oncology
Services/Programs
Leukemia
Oncology
Clinical Titles
Chief of Staff, DFCI
Senior Associate in Medicine
Academic Appointment
Professor of Pediatrics, Harvard Medical School
Board Certification(s)
Pediatrics
|
| |
|
Medical/Dental School
Wayne State University School of Medicine, Detroit, MI (1967)
Internship
New England Medical Center, Boston, MA (07/67 to 06/68)
Residency
Children's Hospital of Philadelphia - Philadelphia, PA 0768 to 06/69 and Hospital for Sick Children, London ENGLAND 07/69 to 06/70
Fellowship
Children's Hospital Boston/Dana Farber Cancer Institute, Boston, MA (07/72 to 06/75)
Research site for Stephen Sallan, MD
Acute Lymphoblastic Leukemia
- Biology, complications and therapy of acute lymphoblastic leukemia (N Engl J Med 332:1738, 1995; Blood 97:1211, 2001; J Clin Oncol 19:1040, 2001; 20:237, 2002; 20:1677, 2002; 21: 2953, 2003; 21: 3616, 2003 and 22:2701, 2004; Blood 102: 4520, 2003; 103:3544, 2004 and 103:4602, 2004; Blood 106:1749, 2005; Blood 106:2484, 2005; Cancer Res 65:10050, 2005; Blood 107: 4508, 2006
- Involvement of the TEL oncogene as a favorable risk factor in childhood ALL; detection, quantitation and prognostic implications of residual disease (Blood 88:4252, 1996; Blood 92:4792, 1998)
- Adoptive T-cell therapy for ALL (Blood 94:3531, 1999; 98:533, 2001)
- Prevention of anthracycline-induced cardiac injury (N Engl J Med 351:145, 2004; Pediatr 115:1613, 2005; J Clin Oncol 23:2629, 2005)
- Targeting FLT3 in MLL- rearranged Leukemias (Blood 106:2484, 2005)
|
Previous |
Next
|
Return to Search Results
|
|
|
